MedTrace Logo

Quadrant Versus Superficial Parotidectomy

NCT01607866 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2016-11-08

No results posted yet for this study

Summary

The most common benign tumor of the parotid gland is the so called pleomorphic adenoma. Although benign, this tumor may recur after surgical removal due to tumor cells left behind during the surgical operation. Thus, pleomorphic adenomas have been treated with wide resection similar to malignant tumors. This extensive surgery often leads to injury to the motor nerves responsible for facial expression and eye protection. The investigators propose less extensive surgery which should be thorough enough to prevent tumor recurrence while keeping the facial nerve out of risk.

Conditions

  • Pleomorphic Adenoma of the Parotid Gland

Interventions

PROCEDURE

Quadrant parotidectomy

Excision of one quadrant of the parotid gland which is comparable to half of the superficial lobe of the gland

PROCEDURE

Superficial parotidectomy

Excision of the whole superficial lobe of the parotid gland

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Osama Hussein, MD, PhD · Mansoura University

  • Adel Denewer, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-07-31
Completion
2016-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01607866 on ClinicalTrials.gov